223 related articles for article (PubMed ID: 26292325)
1. Unique Determinants of Neuraminidase Inhibitor Resistance among N3, N7, and N9 Avian Influenza Viruses.
Song MS; Marathe BM; Kumar G; Wong SS; Rubrum A; Zanin M; Choi YK; Webster RG; Govorkova EA; Webby RJ
J Virol; 2015 Nov; 89(21):10891-900. PubMed ID: 26292325
[TBL] [Abstract][Full Text] [Related]
2. Highly pathogenic avian influenza H7N9 viruses with reduced susceptibility to neuraminidase inhibitors showed comparable replication capacity to their sensitive counterparts.
Tang J; Zhang J; Zhou J; Zhu W; Yang L; Zou S; Wei H; Xin L; Huang W; Li X; Cheng Y; Wang D
Virol J; 2019 Jul; 16(1):87. PubMed ID: 31266524
[TBL] [Abstract][Full Text] [Related]
3. Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferrets.
Ilyushina NA; Seiler JP; Rehg JE; Webster RG; Govorkova EA
PLoS Pathog; 2010 May; 6(5):e1000933. PubMed ID: 20523902
[TBL] [Abstract][Full Text] [Related]
4. Competitive Fitness of Influenza B Viruses Possessing E119A and H274Y Neuraminidase Inhibitor Resistance-Associated Substitutions in Ferrets.
Pascua PN; Marathe BM; Burnham AJ; Vogel P; Webby RJ; Webster RG; Govorkova EA
PLoS One; 2016; 11(7):e0159847. PubMed ID: 27466813
[TBL] [Abstract][Full Text] [Related]
5. Impact of the H274Y Substitution on N1, N4, N5, and N8 Neuraminidase Enzymatic Properties and Expression in Reverse Genetic Influenza A Viruses.
Gaymard A; Picard C; Vazzoler G; Massin P; Frobert E; Sabatier M; Barthelemy M; Valette M; Ottmann M; Casalegno JS; Lina B; Escuret V
Viruses; 2024 Mar; 16(3):. PubMed ID: 38543754
[TBL] [Abstract][Full Text] [Related]
6. Recombinant A(H6N1)-H274Y avian influenza virus with dual drug resistance does not require permissive mutations to retain the replicative fitness in vitro and in ovo.
Bialy D; Richardson S; Chrzastek K; Bhat S; Polo N; Freimanis G; Iqbal M; Shelton H
Virology; 2024 Feb; 590():109954. PubMed ID: 38086284
[TBL] [Abstract][Full Text] [Related]
7. Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140.
Bantia S; Ghate AA; Ananth SL; Babu YS; Air GM; Walsh GM
Antimicrob Agents Chemother; 1998 Apr; 42(4):801-7. PubMed ID: 9559786
[TBL] [Abstract][Full Text] [Related]
8. Detection of oseltamivir-resistant zoonotic and animal influenza A viruses using the rapid influenza antiviral resistance test.
Hodges EN; Mishin VP; De la Cruz J; Guo Z; Nguyen HT; Fallows E; Stevens J; Wentworth DE; Davis CT; Gubareva LV
Influenza Other Respir Viruses; 2019 Jun; 13(5):522-7. PubMed ID: 31187572
[TBL] [Abstract][Full Text] [Related]
9. Microsecond dynamics of H10N7 influenza neuraminidase reveals the plasticity of loop regions and drug resistance due to the R292K mutation.
Sk MF; Samanta S; Poddar S; Kar P
J Comput Chem; 2024 Feb; 45(5):247-263. PubMed ID: 37787086
[TBL] [Abstract][Full Text] [Related]
10. New insights into the neuraminidase-mediated hemagglutination activity of influenza A(H3N2) viruses.
Gao R; Pascua PNQ; Nguyen HT; Chesnokov A; Champion C; Mishin VP; Wentworth DE; Gubareva LV
Antiviral Res; 2023 Oct; 218():105719. PubMed ID: 37717821
[TBL] [Abstract][Full Text] [Related]
11. Amino acids responsible for the absolute sialidase activity of the influenza A virus neuraminidase: relationship to growth in the duck intestine.
Kobasa D; Wells K; Kawaoka Y
J Virol; 2001 Dec; 75(23):11773-80. PubMed ID: 11689658
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling and phylogenetic analyses highlight the role of amino acid 347 of the N1 subtype neuraminidase in influenza virus host range and interspecies adaptation.
Elli S; Raffaini G; Guerrini M; Kosakovsky Pond S; Matrosovich M
Front Microbiol; 2023; 14():1309156. PubMed ID: 38169695
[TBL] [Abstract][Full Text] [Related]
13. Molecular distribution of amino acid substitutions on neuraminidase from the 2009 (H1N1) human influenza pandemic virus.
Quiliano M; Valdivia-Olarte H; Olivares C; Requena D; Gutiérrez AH; Reyes-Loyola P; Tolentino-Lopez LE; Sheen P; Briz V; Muñoz-Fernández MA; Correa-Basurto J; Zimic M
Bioinformation; 2013; 9(13):673-9. PubMed ID: 23930018
[TBL] [Abstract][Full Text] [Related]
14. Preliminary crystallographic analysis of neuraminidase N2 from a new influenza A virus.
Gao F; Bao J
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Aug; 69(Pt 8):861-3. PubMed ID: 23908028
[TBL] [Abstract][Full Text] [Related]
15. Environmental resistance development to influenza antivirals: a case exemplifying the need for a multidisciplinary One Health approach including physicians.
Järhult JD
Acta Vet Scand; 2018 Jan; 60(1):6. PubMed ID: 29370857
[TBL] [Abstract][Full Text] [Related]
16. Neuraminidase Activity Modulates Cellular Coinfection during Influenza A Virus Multicycle Growth.
Guo Z; He Y; Xu J; Benegal AN; Brody SL; Vahey MD
mBio; 2023 Jun; 14(3):e0359122. PubMed ID: 37078858
[TBL] [Abstract][Full Text] [Related]
17. Characterizing loop dynamics and ligand recognition in human- and avian-type influenza neuraminidases via generalized born molecular dynamics and end-point free energy calculations.
Amaro RE; Cheng X; Ivanov I; Xu D; McCammon JA
J Am Chem Soc; 2009 Apr; 131(13):4702-9. PubMed ID: 19296611
[TBL] [Abstract][Full Text] [Related]
18. Zoonotic infections by avian influenza virus: changing global epidemiology, investigation, and control.
Kang M; Wang LF; Sun BW; Wan WB; Ji X; Baele G; Bi YH; Suchard MA; Lai A; Zhang M; Wang L; Zhu YH; Ma L; Li HP; Haerheng A; Qi YR; Wang RL; He N; Su S
Lancet Infect Dis; 2024 Jun; ():. PubMed ID: 38878787
[TBL] [Abstract][Full Text] [Related]
19. Dual Acting Neuraminidase Inhibitors Open New Opportunities to Disrupt the Lethal Synergism between Streptococcus pneumoniae and Influenza Virus.
Walther E; Xu Z; Richter M; Kirchmair J; Grienke U; Rollinger JM; Krumbholz A; Saluz HP; Pfister W; Sauerbrei A; Schmidtke M
Front Microbiol; 2016; 7():357. PubMed ID: 27047471
[TBL] [Abstract][Full Text] [Related]
20. Structure-based design of stabilized recombinant influenza neuraminidase tetramers.
Ellis D; Lederhofer J; Acton OJ; Tsybovsky Y; Kephart S; Yap C; Gillespie RA; Creanga A; Olshefsky A; Stephens T; Pettie D; Murphy M; Sydeman C; Ahlrichs M; Chan S; Borst AJ; Park YJ; Lee KK; Graham BS; Veesler D; King NP; Kanekiyo M
Nat Commun; 2022 Apr; 13(1):1825. PubMed ID: 35383176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
